Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 318558011000036111 | benserazide 12.5 mg + levodopa 50 mg capsule, 100 capsules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 318560011000036119 | levodopa 50 mg + benserazide 12.5 mg capsule, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa 50 mg + benserazide 12.5 mg capsule, 100 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| levodopa 50 mg + benserazide 12.5 mg capsule, 100 | has MPUU | levodopa 50 mg + benserazide 12.5 mg capsule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Madopar 62.5 capsule, 100 | Is a | True | levodopa 50 mg + benserazide 12.5 mg capsule, 100 | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR